20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T12256 | NS8593 hydrochloride | NS8593 HCl | Potassium Channel |
NS8593 hydrochloride (NS8593 HCl) is a potent and selective inhibitor of small conductance Ca2+-activated K+ channels (SK channels) . | |||
T3518 | GSK269962A | GSK269962B,GSK 269962,GSK269962A HCl | ROCK , S6 Kinase |
GSK269962A (GSK269962A HCl) is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively. | |||
T31207 | GSK233705 | Darotropium bromide,GSK 233705,GSK-233705B,GSK233705,GSK233705B,GSK-233705,GSK 233705B | AChR |
GSK233705 (Darotropium bromide) is a muscarinic receptor antagonist used in conjunction with the prevention and treatment of chronic obstructive pulmonary disease (COPD) and asthma in humans. | |||
T2436 | GSK2801 | Apoptosis , Epigenetic Reader Domain | |
GSK2801 is an effective, specific and cell active acetyl-lysine competitive inhibitor of BAZ2A(Kd: 136 nM) and BAZ2B(Kd: 257 nM) bromodomains. | |||
T4418 | GSK2879552 2HCl (1401966-69-5(free base)) | Histone Demethylase | |
GSK2879552 is an orally available, irreversible inhibitor of lysine specific demethylase 1 (LSD1), with potential antineoplastic activity. | |||
T6850L | GSK2292767 FA | GSK2292767 FA(1254036-66-2 Free base) | PI3K |
GSK2292767 FA is a potent and selective inhibitor of PI3Kδ (pIC50 : 10.1).GSK2292767 FA is more than 500-fold more selective than other PI3K isoforms.GSK2292767 FA can be used in the study of respiratory diseases. | |||
T11485 | GSK2643943A | DUB | |
GSK2643943A is a deubiquitylating enzyme (DUB) inhibitor, with an IC 50 of 160 nM for USP20/Ub-Rho. GSK2643943A has anti-tumor efficacy. | |||
T15436 | GSK2838232 | HIV Protease | |
GSK2838232 inhibit HIV reverse transcriptase activity across a broad panel of HIV-1 isolates,GSK2838232 is novel human immune virus (HIV) maturation inhibitor. | |||
T15432 | GSK256073 | GPR , Others | |
GSK256073 is an orally active GPR109A agonist. GSK256073 also is a long-lasting and non-flushing HCA2 (hydroxy-carboxylic acid receptor 2) full agonist (pEC50: 7.5). GSK256073 acutely improves glucose homeostasis via inh... | |||
T4531 | GSK2200150A | Antibacterial | |
GSK2200150A is an anti-tuberculosis (TB) agent identified by high-throughput screening (HTS) campaign. | |||
T6054 | GSK256066 | PDE | |
GSK256066 is a selective PDE4B(equal affinity to isoforms A-D) inhibitor with IC50 of 3.2 pM, >380, 000-fold selectivity versus PDE1/2/3/5/6 and >2500-fold selectivity against PDE4B versus PDE7.Phase 2. | |||
T27454 | GSK2008607 | Raf | |
GSK2008607 is a potent B-RafV600E inhibitor with anticancer activity and can be used to study breast, colorectal, melanoma, thyroid, and ovarian cancers. | |||
T2073 | GSK2636771 | GSK 2636771,GSK-2636771 | PI3K |
GSK2636771, an effective, specific, orally bioavailable, PI3Kβ inhibitor, has been used in cancer, lymphoma, solid neoplasm, recurrent solid neoplasm, and advanced malignant neoplasm. | |||
T11488 | GSK2850163 | IRE1 | |
GSK2850163 is a novel inhibitor of inositol-requiring enzyme-1 alpha (IRE1α) which can inhibit RNase activity and IRE1α kinase activity (IC50s: 200 and 20 nM). | |||
T9830 | GSK2556286 | GSK286 | Antibacterial |
GSK2556286 (GSK286) is an orally active inhibitor of Mycobacterium tuberculosis (M. tuberculosis).GSK2556286 inhibits the growth of human macrophages with an IC50 value of 0.07 μM.GSK2556286 is effective against both mul... | |||
T7151 | GSK2982772 | RIP kinase | |
GSK2982772 is an inhibitor of receptor interacting serine/threonine kinase 1 (RIPK1)with IC50 values of 16 nM and 20 nM for human and monkey RIP1, respectively. | |||
T2348 | GSK2334470 | PDK | |
GSK2334470 is a novel PDK1 inhibitor (IC50: ~10 nM, in a cell-free assay), with no inhibitory at other close related AGC-kinases. | |||
T2281 | GSK2256098 | GSK 2256098,GSK-2256098,GTPL7939 | Apoptosis , FAK |
GSK2256098 (GTPL7939) is a small molecule FAK kinase inhibitor. | |||
T5640 | GSK2193874 | TRP/TRPV Channel | |
GSK2193874 was identified as a selective, orally active TRPV4 blocker. | |||
T27471 | GSK299115A | GSK 299115A,GSK-299115A | GRK |
GSK299115A (GSK-299115A) is a selective ROCK1 Inhibitor. GSK299115A exhibits IC50 of 8nM, 620nM, 560nM for ROCK1, RSK1, p70S6K, respectively. |